fig2
From: Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
![Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma](https://image.oaes.cc/95d97a06-9c1e-4152-83bf-65cd13a83297/3694.fig.2.jpg)
Figure 2. Changes in response to transarterial radioembolization over time. Response was defined as complete response (CR) or partial response (PR) using modified response evaluation criteria in solid tumors. Non-response was defined as stable disease (SD) or progressive disease (PD). Arrows depict changes in response between 3-month and 6-month imaging. The total box represents the overall count of responders and non-responders to treatment. Two patients (one responder and one non-responder) did not receive 3-month imaging, and initial response was evaluated at 6-month follow-up instead (asterisk)